News & Insights
Nanopharm Announces Launch of New Website
Nanopharm Ltd announces the launch of its new website (www.nanopharm.co.uk). This is part of our rebranding initiative and reflects our evolving business strategy and continued success of the company.
Nanopharm Ltd. is a contract pharmaceutical development company for orally inhaled and nasal drug products (OINDPs). Our core services encompass particle engineering, advanced solid-state characterisation, formulation and product development and dissolution testing of OINDPs.
The updated website introduces our new service technologies such as Nanoplex for advanced materials characterisation of active pharmaceutical ingredients and excipients and our Dissohale technology for dissolution testing of respiratory drug products. We also highlight our product development capabilities, which combines our analytical expertise with our Interhale formulation technologies to expedite rapid early phase development of respiratory drug products from lab to first–in-human clinical trials.
Over the last decade, Nanopharm has built a strong reputation in advanced characterisation, accelerated early phase development of respiratory drug products and bespoke analytical services to aid the development of respiratory drug products within a quality by design framework. Prof. Robert Price, Founder and Director at Nanopharm Ltd, said:” We are very pleased to announce the launch of our new company website, which provides updated information about our business focus, range of technologies and services we offer to our pharmaceutical development partners. The launch of our new web-site marks an important milestone in Nanopharm’s continued growth. We hope you find the web pages informative and we wish to establish this portal as a source of information for those who visit our site.”
In the coming months Nanopharm will be presenting at many international conferences to showcase its technologies and development capabilities. Details regarding our attendance at meetings can be found on our news and insights page (http://nanopharm.co.uk/news-insights/).